The Medicines and Healthcare products Regulatory Agency has issued a summer public safety message on medicine storage, warning that heat exposure can reduce the effectiveness of some products. The communication is presented as a practical reminder rather than a change in rules, but it has immediate consequences for patients travelling with prescription medicines and for pharmacies handling seasonal enquiries. The central point in the government notice is straightforward. Medicines are not all stored in the same way, and hotter conditions can matter. The MHRA says many medicines are intended to be stored below 25°C, while others require refrigeration or protection from light and heat.
The agency identifies several product groups where storage conditions may be especially important, including insulin, certain inhalers, creams for skin conditions and some contraceptives. The notice also extends to medical devices, with the MHRA citing blood glucose monitors and insulin strips among the examples where the accompanying instructions should be followed carefully. Dr Alison Cave, the MHRA's Chief Safety Officer, said summer environments such as parked cars, packed suitcases, caravans and sunny rooms can become much hotter than many people expect. In regulatory terms, that places an everyday summer habit within the wider question of medicine safety and product effectiveness.
For households, the guidance is a reminder that ordinary storage routines can become unsuitable in warmer conditions. The MHRA advises that medicines should be kept in a cool, dry place out of direct sunlight, and it specifically says bathrooms and areas near heat sources are poor choices. The practical reference point is the patient information leaflet or the product packaging. According to the MHRA, those documents set out whether a medicine should be refrigerated, stored at room temperature or protected from light. The agency also notes that patient information leaflets are available online through its website.
The travel element is one of the clearest parts of the message. The MHRA advises against leaving medicines in cars, suitcases or other enclosed spaces that can become very hot during summer journeys. That matters not only for overseas holidays but also for day trips, commutes and caravan breaks where medicines may be left in stationary vehicles or luggage for long periods. For patients, the practical consequence is that storage planning now sits alongside packing prescriptions and checking travel documents. Where a treatment has specific temperature requirements, the government advice indicates that those conditions should be checked before travel rather than after a product has already been exposed to heat.
Community pharmacists are placed at the centre of the response where there is uncertainty. The MHRA tells the public to speak to a pharmacist if they are unsure how a medicine should be stored or if they believe it may have been exposed to excessive heat. That gives pharmacies a clear public-facing role over the summer period: clarifying storage instructions, helping patients distinguish between room-temperature and refrigerated products, and deciding when further clinical advice may be needed. For pharmacy teams, the message is less about a new duty than about applying existing product information carefully in hot weather.
The notice also sets out an escalation route if a product appears not to be working as expected. The MHRA says anyone who suspects a medicine is not performing properly should speak to a pharmacist or doctor and report the issue through the Yellow Card scheme. That reporting step matters because it connects individual concerns to the regulator's wider safety monitoring system. The summer message is therefore not only about prevention; it also directs patients and clinicians towards a formal route for recording suspected medicine or device problems.
Viewed more broadly, the communication shows how the MHRA uses seasonal safety messages to turn product labelling into practical public guidance. The agency, which is an executive agency of the Department of Health and Social Care, regulates medicines and medical devices across the UK and is using that remit here to address a predictable summer risk. For patients, carers and pharmacists, the message is concise. Check the leaflet, follow the storage instructions and do not assume that a car, bag or sunny room is an acceptable temporary location. In plain terms, the guidance is about preserving the safety and effectiveness of medicines before a storage mistake becomes a treatment problem.